In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...